AHL Partners’s Avanos Medical AVNS Stock Holding History

AHL Partners’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$3.23M	Sell	69,901 -76,890	-52%	-$3.53M	0.05%	597
2017 Q3	$6.61M	Sell	146,791 -164,396	-53%	-$7.01M	0.12%	310
2017 Q2	$12.2M	Buy	311,187 +36,072	+13%	+$1.36M	0.26%	58
2017 Q1	$10.5M	Buy	275,115 +223,071	+429%	+$8.69M	0.23%	102
2016 Q4	$1.93M	Buy	52,044 +19,012	+58%	+$679K	0.06%	519
2016 Q3	$1.15M	Sell	33,032 -10,500	-24%	-$368K	0.04%	555
2016 Q2	$1.42M	Buy	+43,532	New	+$1.33M	0.08%	340
2015 Q2	–	Sell	-44,188	Closed	-$2.17M	–	824
2015 Q1	$2.17M	Sell	44,188 -76,176	-63%	-$3.53M	0.09%	484
2014 Q4	$5.47M	Buy	+120,364	New	+$4.73M	0.28%	16

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AHL Partners's AVNS Position: Q4 2017 in Review

AHL Partners reduced its Avanos Medical (AVNS) stake by 52% in Q4 2017, selling an estimated $3.53M and leaving 69,901 shares worth $3.23M. The position accounts for 0.05% of the portfolio, ranked #597.

AHL Partners first reported a position in AVNS in Q4 2014 and has held it in 9 quarters since. The position peaked at $12.2M in Q2 2017. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2017.

AHL Partners held 69,901 shares of Avanos Medical worth $3.23M as of Q4 2017.
AHL Partners sold 76,890 Avanos Medical shares in Q4 2017, an estimated $3.53M.
Avanos Medical made up 0.05% of AHL Partners's portfolio in Q4 2017, its #597 holding.
AHL Partners first reported a position in Avanos Medical in Q4 2014 and has held it in 9 quarters since.
AHL Partners's Avanos Medical position peaked at $12.2M in Q2 2017.
350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.